Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) EV to CFO (2017 - 2025)

Analysis

Celcuity (CELC) EV to CFO (2017 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Celcuity 5.25 Bn 5.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -120.07
Sep 30, 2025 -37.55
Jun 30, 2025 -9.70
Mar 31, 2025 -4.93
Dec 31, 2024 -9.04
Sep 30, 2024 -14.07
Jun 30, 2024 -17.89
Mar 31, 2024 -28.54
Dec 31, 2023 -10.31
Sep 30, 2023 -5.53
Jun 30, 2023 -9.96
Mar 31, 2023 -5.24
Dec 31, 2022 -5.00
Sep 30, 2022 -9.94
Jun 30, 2022 -6.12
Mar 31, 2022 -10.31
Dec 31, 2021 -18.37
Sep 30, 2021 -43.94
Jun 30, 2021 -34.40
Mar 31, 2021 -56.02